Ken Cui – Homart Pharmaceuticals Pty Ltd
View Detailed Executive Profile →Professional Overview
Ken Cui serves as an executive at Homart Pharmaceuticals Pty Ltd, overseeing strategic initiatives and leadership responsibilities.
Professional Experience
| Company | Designation | Period |
|---|---|---|
| Green Natural Eco-agriculture Co. Ltd. | Chief Financial Officer | Oct 2017 – Mar 2021 |
| Modern Media Group | Executive Director | May 2008 – Jul 2015 |
| Wealth-Depot Group | Executive Director | Aug 2015 – Sep 2017 |
| OSRAM | Senior Finance Manager | Aug 1995 – Mar 2001 |
| RR Donnelley Asia | General Manager | Apr 2001 – Apr 2008 |
| Homart Group | Deputy CFO | Oct 2024 – Present |
| Homart Pharmaceuticals Pty Ltd | Chief Financial Officer | May 2022 – Present |
Estimated Net Worth
Estimated Range: ₹0 – ₹1000+ Cr (approx. $0 – $120M+)
Based on publicly accessible filings, industry benchmarks, and leadership compensation patterns.
Executive Contact
Official Email: Via Homart Pharmaceuticals Pty Ltd corporate communication desk.
Personal Contact: Not publicly disclosed.
Frequently Asked Questions
What is Ken Cui's net worth?
Estimated ₹0 – ₹1000+ Cr (approx. $0 – $120M+).
How can I contact them?
Through Homart Pharmaceuticals Pty Ltd's official communication channels.
Is this an official profile?
No — independently created using public data.
Disclaimer
This profile is created for general informational purposes. All details are based on publicly accessible information and independent research. While accuracy is prioritized, content may not always reflect the latest updates.
Nothing here should be interpreted as investment, financial, or legal advice. The individual featured has not authored or endorsed this profile.
Personal information is intentionally withheld. For official matters, please use formal communication channels associated with the respective organization.
Affluense AI – Smarter Insights. Stronger Relationships with Affluents.
Last Updated: December 2025 · Published by Affluense AI (affluense.ai)